The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues

about

The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues

Item

http://www.wikidata.org/entity/Q37287554

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The antiangiogenic agent ZD419 ...... dual carcinoma in deep tissues

@en

The antiangiogenic agent ZD419 ...... ual carcinoma in deep tissues.

@nl

type

Item

label

The antiangiogenic agent ZD419 ...... dual carcinoma in deep tissues

@en

The antiangiogenic agent ZD419 ...... ual carcinoma in deep tissues.

@nl

prefLabel

The antiangiogenic agent ZD419 ...... dual carcinoma in deep tissues

@en

The antiangiogenic agent ZD419 ...... ual carcinoma in deep tissues.

@nl

P1476

The antiangiogenic agent ZD419 ...... dual carcinoma in deep tissues

@en

P2093

A Hills

http://www.w3.org/2001/XMLSchema#string

K Gaballah

http://www.w3.org/2001/XMLSchema#string

M Partridge

http://www.w3.org/2001/XMLSchema#string

R Oakley

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R

Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.

Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis

ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Molecular determinants of ovarian cancer plasticity.

Molecular markers for diagnosis and prognosis.

ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.

Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.

P2888

sj.bjc.6605092

P304

418-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605092

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Anderson J Ryan

P577

2009-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26686744

http://www.w3.org/2001/XMLSchema#string

P698

19623179

http://www.w3.org/2001/XMLSchema#string

P932

2720249

http://www.w3.org/2001/XMLSchema#string